Zhu Kang-Shun, Meng Xiao-Chun, Huang Ming-Sheng, Qian Jie-Sheng, Guan Shou-Hai, Li Zheng-Ran, Jiang Zai-Bo, Shan Hong, Yang Yang, Chen Gui-Hua
Department of Radiology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.
Zhonghua Yi Xue Za Zhi. 2009 Aug 18;89(31):2195-8.
To explore the influence of early hepatic artery ischemia on the occurrence and prognosis of biliary complications after orthotopic liver transplantation (OLT), and the value of early hepatic arterial interventional therapy.
In the 720 recipients who received OLT in our hospital from October 2003 to June 2007, 32 cases were detected hepatic artery stenosis (HAS, 30 cases) or hepatic artery thrombosis (HAT, 2 cases) by color Doppler Ultrasound from 4 to 65 days (mean, 25 +/- 15) after OLT. All of them were confirmed by DSA and/or CT angiography. Of the 32 patients, 20 were treated by hepatic arterial interventional therapy. The end-point of follow-up was the time of patient's death and retransplantation.
In this study, 20 cases developed biliary complications, including the common bile duct stenosis in 2 cases, intra- and extra hepatic bile duct stenosis in 13 cases and multiple intrahepatic bile duct stenosis in 5 cases. Among them, 2 patients complicated with bile leakage, 4 with biloma and 3 with liver abscess. Of the 20 patients, 8 with HAS received successful hepatic arterial interventional therapy which was performed two weeks after HAS detected; 10 with HAS didn't receive hepatic arterial interventional therapy; 1 with HAT received successful thrombolysis; 1 with HAS received failed hepatic artery stent implantation. During a median follow-up of 262 days (range, 22 -517 days), 10 patients died, 6 underwent retransplantation, and the other 4 survived; cumulated survival rates at 6, 12 and 24 months were 60.0%, 34.9% and 0, respectively. 12 cases didn't develop biliary complications. Nine of them received successful hepatic arterial interventional therapy within 2 weeks HAS detected, 2 with acute rejection received flushing anti-rejection therapy, 1 with HAT received retransplantation because of unsuccessful thrombolysis. During a median follow-up of 952 days (range, 14 - 1398 days), 3 patients died, 1 underwent retransplantation, and the other 8 survived; cumulated survival rates at 6, 12 and 24 months were 75%, 66.7% and 66.7%, respectively.
Early hepatic artery ischemia after OLT is an important agent for biliary complications. Early and successful hepatic arterial interventional therapy helped to reduce the incidence of biliary complications and improve the patients' prognosis.
探讨原位肝移植(OLT)术后早期肝动脉缺血对胆道并发症发生及预后的影响,以及早期肝动脉介入治疗的价值。
2003年10月至2007年6月在我院接受OLT的720例受者中,32例在OLT术后4至65天(平均25±15天)经彩色多普勒超声检测发现肝动脉狭窄(HAS,30例)或肝动脉血栓形成(HAT,2例)。均经DSA和/或CT血管造影确诊。32例患者中,20例接受了肝动脉介入治疗。随访终点为患者死亡及再次移植时间。
本研究中,20例发生胆道并发症,包括胆总管狭窄2例、肝内外胆管狭窄13例、多发性肝内胆管狭窄5例。其中,2例合并胆漏,4例合并胆汁瘤,3例合并肝脓肿。20例患者中,8例HAS患者在发现HAS后2周接受肝动脉介入治疗成功;10例HAS患者未接受肝动脉介入治疗;1例HAT患者溶栓成功;1例HAS患者肝动脉支架植入失败。中位随访262天(范围22 - 517天),10例患者死亡,6例接受再次移植,4例存活;6、12和24个月累积生存率分别为60.0%、34.9%和0。12例未发生胆道并发症。其中9例在发现HAS后2周内接受肝动脉介入治疗成功,2例急性排斥反应患者接受冲洗抗排斥治疗,1例HAT患者因溶栓失败接受再次移植。中位随访952天(范围14 - 1398天),3例患者死亡,1例接受再次移植,8例存活;6、12和24个月累积生存率分别为75%、66.7%和66.7%。
OLT术后早期肝动脉缺血是胆道并发症的重要因素。早期成功的肝动脉介入治疗有助于降低胆道并发症发生率,改善患者预后。